Study title: Ugur G., Erhan E., Kocabas S;, Ozyar B. Anaesthetic/analgesic management of extracorporeal shock wave lithotripsy in paediatric patients. Paediatric Anaelgesia 13: p. 83-87; 2003Ugur G., Erhan E., Kocabas S;, Ozyar B. Anaesthetic/analgesic management of extracorporeal shock wave lithotripsy in paediatric patients. Paediatric Anaelgesia 13: p. 83-87; 2003
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Anesthesia and Analgesia [E03] | |||||
| Brands: Please see report, Please see report, Please see report | |||||
| MAH holders: Please see report, Please see report, Please see report | |||||
| Assessment: | |||||
| Active substance: ALFENTANIL | |||||
| ATC code: N01AH02 | |||||
| Document link: ugur_alfentanil.pdf | |||||
| Document date: 2011-11-22 | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | Y | |